Discover how Vivos Therapeutics transformed Orofacial therapy delivery with blueBriX’s personalized value-based care tools

Vivos Therapeutics, a pioneer in non-invasive treatment for obstructive sleep apnea (OSA), was determined to expand its clinical impact beyond traditional care models. When it acquired MyoSync, a company specializing in Orofacial Myofunctional Therapy (OMT), it gained not just a treatment extension—but an opportunity to rethink how therapy could be delivered.

This wasn’t Vivos’s first partnership with blueBriX. Previously, the two teams collaborated to build AireO2, a dental EHR platform designed to simplify provider workflows and centralize patient data across practices. That solution helped Vivos rapidly expand its customer base by improving clinical efficiency and enabling consistent care delivery across its growing network of providers.

Building on the success of AireO2, Vivos and blueBriX set out to solve a new challenge: enabling mobile-first patient engagement tailored to Orofacial therapy needs. The result was the MyoSync App—a unified platform that empowers patients with personalized digital tools while giving clinicians the oversight and structure needed to deliver better outcomes.